Natural killer cells and interleukin-12 in patients with advanced cervical cancer under neoadjuvant chemotherapy

Brazilian Journal of Medical and Biological Research

Volumn 29, Issue 4, 1996, Pages 473-477

  Marana, H R C ^a   Andrade, J M ^a   Silva, J S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cervical cancer; IL 12; natural killer cells; neoadjuvant chemotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; INTERLEUKIN 12;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; UTERINE CERVIX CANCER;

CHEMOTHERAPY, ADJUVANT; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; INTERLEUKIN-12; KILLER CELLS, NATURAL; T-LYMPHOCYTE SUBSETS; UTERINE CERVICAL NEOPLASMS;

EID: 0029968664     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Schreiber H (1993). Tumor immunology In: William EP (Editor). Fundamental Immunology. Raven Press, New York, 1143-1178
2. Garzetti GG, Cignitti M, Marchegiane F, Ciavantti A, Tranquilli AL, Fabrts N & Romanini C (1992). Natural killer cell activity in patients with gynecologic malignancies: correlation with histologic grading and stage of disease. Gynecology and Obstetric Investigation. 34: 49-51
3. Ronald B & Herberman MD (1992). Tumor immunology. Journal of the American Medical Association. 268: 2935-2939.
4. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clarck SC & Trinchien G (1991). Induction of Interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. Journal of Experimental Medicine, 173: 869-879.
5. +, NK cells. Journal of Immunology, 148: 2429-2436.
6. Kobayashi M, Fitz L, Ryan M. Hewck RM, Clark CS, Chan S. Loudon R, Sherman BP & Trinchieri G (1989). Identification and purification of natural killer stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. Journal of Experimental Medicine, 170: 827-845.
7. Chehimi J. Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE & Trinchieri G (1993) Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. European Journal of Immunology, 23: 1826-1830.
8. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahae C, Young D, Hermann SH & Ritz J (1992) Responses of human natural killer (NK) cells to NK stimulatory factor (NKSF) cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. Journal of Experimental Medicine, 175: 779-788
9. International Federation of Gynecology and Obstetrics (1988). Report on the results of treatment in gynecological cancer. FIGO, 20: 29-71.
10. Lanier L, Le A. Civin C, Loken M & Phillips J (1986). The relationship of CD16 (leu-11) and leu-19 (NKH-1) antigen expression in human peripheral blood NK cells and cytotoxic lymphocytes. Journal of Immunology, 136: 4480-4486
11. Bryant J, Day R, Whiteside TL & Herberman RB (1992). Calculation of lytic units for the expression of cell-mediated cytotoxicity. Journal of Immunological Methods. 146: 91-106.
12. Murphy EE, Terres G, Mecatonia SE, Hsieh CS, Mattson J, Lamer L, Wysocka M, Trinchien G, Murphy K & O'Garra A (1994). B7 and interleukin-12 cooperate for proliferation and interferon-γ production by mouse T helper clones that are unresponsive to B7 costimulation. Journal of Experimental Medicine, 180: 223-231.
13. Elsasser-Beile U, von Kleist S. Sauther W. Gallati H & Monting S (1992). Impaired cytokine production in whole blood cell cultures of patients with gynecological carcinomas in different clinical stages. British Journal of Cancer. 68: 32-36.
14. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF & Gately MK (1993). Antitumor and antimetastatic activity of interleukin 12 against murine tumors. Journal of Experimental Medicine, 178: 1223-1230.